Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution

Journal of Infectious Diseases

Volumn 183, Issue 4, 2001, Pages 657-661

  Blankson, J N ^a   Gallant, J E ^a   Siliciano, R F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS DNA; ZIDOVUDINE;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDA ALBICANS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV ANTIGENS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; TETANUS TOXOID;

EID: 0035865868     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/318545     Document Type: Article

References (15)

1. Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection
2. + T cell homeostasis and function in advanced HIV-1 disease
3. Long-lasting recovery of CD4 T cell function and viral load after HAART in advanced HIV-1 disease
4. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens
5. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV + long-term survivor
6. + T cell responses associated with control of viremia
7. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir
8. Improvement in cell-mediated immune function during potent anti-HIV-1 therapy with ritonavir plus saquinavir
9. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
10. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
11. Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease: Immunology Study Group of Spanish EARTH-1 Study
12. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
13. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
14. Changes in thymic function with age and during the treatment of HIV infection
15. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy